Insider · CIK 0001726184

Barrans Russell

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001726184

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-07-08	EVFMEvofem Biosciences, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−20K sh	$0.97	−$19.5K	448,554
2021-06-11	EVFMEvofem Biosciences, Inc.P Purchase	Chief Commercial Officer	PPurchase	+18.2K sh	$1.14	+$20.7K	468,552
2021-05-20	EVFMEvofem Biosciences, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−31.5K sh	$0.86	−$27.1K	450,372
2021-02-03	EVFMEvofem Biosciences, Inc.A Award	Chief Commercial Officer	AAward	+200K sh	—	—	481,852
2021-02-03	EVFMEvofem Biosciences, Inc. · Stock option (right to buy)A Award	Chief Commercial Officer	AAward	+150K sh	—	—	150,000
2020-09-11	EVFMEvofem Biosciences, Inc.P Purchase	Chief Commercial Officer	PPurchase	+3,000 sh	$2.08	+$6,240	279,052
2020-09-10	EVFMEvofem Biosciences, Inc.P Purchase	Chief Commercial Officer	PPurchase	+1,000 sh	$2.71	+$2,710	276,052
2020-07-08	EVFMEvofem Biosciences, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−20.4K sh	$3.30	−$67.3K	275,052
2020-06-05	EVFMEvofem Biosciences, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−15.5K sh	$3.31	−$51.2K	293,509
2020-05-22	EVFMEvofem Biosciences, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−19.5K sh	$4.99	−$97.2K	308,964
2020-05-06	EVFMEvofem Biosciences, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−3,802 sh	$5.24	−$19.9K	328,438
2020-02-19	EVFMEvofem Biosciences, Inc.S Sale	Chief Commercial Officer	SSale	−15K sh	$6.50	−$97.2K	332,240
2020-02-05	EVFMEvofem Biosciences, Inc.A Award	Chief Commercial Officer	AAward	+899 sh	$5.21	+$4,683.79	197,197
2020-02-05	EVFMEvofem Biosciences, Inc.A Award	Chief Commercial Officer	AAward	+150K sh	—	—	347,197
2020-02-05	EVFMEvofem Biosciences, Inc. · Stock option (right to buy)A Award	Chief Commercial Officer	AAward	+100K sh	—	—	100,000
2020-01-16	EVFMEvofem Biosciences, Inc.S Sale	Chief Commercial Officer	SSale	−1,578 sh	$6.50	−$10.3K	196,298
2019-11-25	EVFMEvofem Biosciences, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−9,277 sh	$6.22	−$57.7K	197,876
2019-11-20	EVFMEvofem Biosciences, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−9,044 sh	$5.74	−$51.9K	207,153
2019-08-22	EVFMEvofem Biosciences, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−962 sh	$5.13	−$4,935.06	216,197
2019-07-08	EVFMEvofem Biosciences, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−13.3K sh	$4.99	−$66.2K	217,159
2019-07-08	EVFMEvofem Biosciences, Inc.A Award	Chief Commercial Officer	AAward	+150K sh	—	—	230,416
2019-06-10	EVFMEvofem Biosciences, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−5,965 sh	$6.36	−$37.9K	80,416
2019-04-01	EVFMEvofem Biosciences, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−1,160 sh	$3.55	−$4,118	86,381
2019-02-25	EVFMEvofem Biosciences, Inc.A Award	Chief Commercial Officer	AAward	+75K sh	—	—	87,541
2018-11-28	EVFMEvofem Biosciences, Inc. · Stock option (right to buy)A Award	Chief Commercial Officer	AAward	0 sh	—	—	100,000
2018-11-28	EVFMEvofem Biosciences, Inc. · Stock option (right to buy)A Award	Chief Commercial Officer	AAward	+100K sh	—	—	100,000
2018-11-21	EVFMEvofem Biosciences, Inc.P Purchase	Chief Commercial Officer	PPurchase	+279 sh	$3.55	+$990.45	12,820
2018-08-10	EVFMEvofem Biosciences, Inc.P Purchase	Chief Commercial Officer	PPurchase	+3,715 sh	$1.98	+$7,355.7	12,541
2018-07-31	EVFMEvofem Biosciences, Inc. · Stock option (right to buy)A Award	Chief Commercial Officer	AAward	+98.8K sh	—	—	98,800
2018-07-02	EVFMEvofem Biosciences, Inc.F Tax Payment	Chief Commercial Officer	FTax Payment	−2,840 sh	$2.46	−$6,986.4	8,826
2018-07-02	EVFMEvofem Biosciences, Inc.A Award	Chief Commercial Officer	AAward	+11.7K sh	—	—	11,666
2018-03-12	EVFMEvofem Biosciences, Inc. · Stock option (right to buy)A Award	Chief Commercial Officer	AAward	+260K sh	—	—	260,000
2018-01-17	EVFMEvofem Biosciences, Inc. · Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+3,850 sh	—	—	3,850
2018-01-17	EVFMEvofem Biosciences, Inc. · Stock Option (right to buy)A Award	Chief Commercial Officer	AAward	+1,283 sh	—	—	1,283

Recent filings

Accepted (ET)
Jul 94
Barrans Russell0001618835-21-000158
SEC(opens sec.gov)
Jun 114
Barrans Russell0001618835-21-000150
SEC(opens sec.gov)
May 214
Barrans Russell0001618835-21-000136
SEC(opens sec.gov)
Feb 34
Barrans Russell0001618835-21-000013
SEC(opens sec.gov)
Sep 114
Barrans Russell0001618835-20-000220
SEC(opens sec.gov)
Jul 94
Barrans Russell0001618835-20-000206
SEC(opens sec.gov)
Jun 84
Barrans Russell0001618835-20-000186
SEC(opens sec.gov)
May 264
Barrans Russell0001618835-20-000156
SEC(opens sec.gov)
May 84
Barrans Russell0001618835-20-000115
SEC(opens sec.gov)
Feb 214
Barrans Russell0001618835-20-000027
SEC(opens sec.gov)
Feb 74
Barrans Russell0001618835-20-000023
SEC(opens sec.gov)
Jan 214
Barrans Russell0001618835-20-000013
SEC(opens sec.gov)
Nov 264
Barrans Russell0001618835-19-000204
SEC(opens sec.gov)
Nov 214
Barrans Russell0001618835-19-000186
SEC(opens sec.gov)
Aug 264
Barrans Russell0001618835-19-000156
SEC(opens sec.gov)
Jul 104
Barrans Russell0001618835-19-000141
SEC(opens sec.gov)

Companies

Evofem Biosciences, Inc.Chief Commercial OfficerEVFM

Address

C/O EVOFEM BIOSCIENCES, INC. 12400 HIGH BLUFF DRIVE, SUITE 600

SAN DIEGO, CA, 92130